Written Question·Department of Health and Social Care·UIN HL202
Tabled: 18 May 2026
Question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 11 March (HL15195), what assessment they have made of the suitability of conventional cost-effectiveness assessments for medicines where structural evidence constraints a